A team of disease experts and health economists at Johns Hopkins University, Baltimore warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.
A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to physicians at Duke Cancer Institute, Durham, NC.
Screening for prostate cancer has significant drawbacks, but limited screening could be beneficial, according to an analysis of results from a large European study.
About 40% of urologists report symptoms of burnout, a recent national survey of more than 7,000 physicians finds.
PODCAST Efficacy and safety study comparing Oxybutynin 3% topical gel vs. placebo in adults with Overactive Bladder Syndrome.
Two companies with products in the urology market have signed new distribution agreements.
Due to manufacturing issues, a formulation of the bladder cancer treatment bacillus Calmette-Guérin is currently unavailable from one manufacturer.
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments when treated at a urology-owned radiation oncology practice versus other facilities, according to a recent study.
Robot-assisted radical prostatectomy appears to provide better functional results for incontinence and potency, according to the authors of a study from Turin, Italy.
Researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center in New York have successfully developed and tested a new prostate cancer screening method.
Fesoterodine fumarate (Toviaz) appears to reduce urge urinary incontinence in patients with overactive bladder who had a suboptimal response to tolterodine tartrate extended release (Detrol LA), according to a phase IV study.
The impact of the proposed Centers for Medicare & Medicaid Services payment cuts to radiation oncology could severely impact community-based cancer care across the country, according to a recent survey from the American Society for Radiation Oncology.
As a man's waistline grows, so can his experience with sexual dysfunction and frequent urination, report researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center, New York.
A team of scientists has discovered a key factor that drives chemotherapy resistance
Multidisciplinary care is associated with increased selection of active surveillance in men with low-risk prostate cancer, according to a recent study.
The increase in the use of magnetic resonance imaging and computed tomography for patients in the U.S. slowed to between 1% and 3% per year between 2006 and 2009, ending a decade of growth that had exceeded 6% annually, according to a study published online in Health Affairs (July 25, 2012).
Pregabalin (Lyrica) capsules do not affect reproductive function in healthy males when compared with placebo, according to results from a study conducted as a post-approval commitment required by the FDA.
A new, nationwide survey of U.S. physicians shows that 42% of urologists say they will retire by 2022.
Researchers from the University of California, San Diego and the University of Tennessee, Memphis, have identified a link between total nephrectomy and erectile dysfunction.
Eliminating the PSA test would be taking a big step backwards and would likely result in rising numbers of men with metastatic cancer at the time of diagnosis, according to a recent analysis.
This was written by Sivaprasad Madduri, MD, a urologist at NorthWest Clinic, Poplar Bluff, MO.
Testosterone, a hormone somewhat relegated to background status for many years, is moving to the fore as a central factor in men's health and disease.
For urologists who strongly oppose key provisions of the Patient Protection & Affordable Care Act (ACA), upheld by the U.S. Supreme Court in late June, the best hope for change may lie in the ballot box rather than in the halls of Congress.
A final analysis of data after 11 years of follow-up in the European Randomised Study of Screening for Prostate Cancer (ERSPC) shows a highly statistically significant benefit of PSA screening for reducing prostate cancer mortality.
Neurotrophic factors that appear in interstitial cystitis/bladder pain syndrome (IC/BPS) patients' urine and disappear with onabotulinumtoxinA (Botox) treatment point to peptidergic primary bladder afferent nerves as the root of patients' pain and other symptoms.
Both the clinical presentation and management of incident kidney stone disease appear to vary by age such that older individuals are more likely than their younger counterparts to present with a concurrent urinary tract infection (UTI), have no or atypical pain, and require surgical intervention.
Although 24-hour urinary sodium excretion is considered the gold standard for assessing a person's dietary sodium intake, findings of a study call this practice into question.
For years, some urologists and physical therapists have been saying that the pelvic floor is contracted and shortened because of hypertonicity in patients with interstitial cystitis/painful bladder syndrome (IC/PBS), contributing to their misery. Now, using magnetic resonance imaging measurements, researchers have some physical confirmation that these patients do indeed have a contracted pelvic floor.
Interim data from a phase III trial of a novel radiation agent in men with castration-resistant prostate cancer (CRPC) showed the agent's efficacy to be significantly sufficient to bring the trial to a halt at a planned interim analysis so as to be able offer the agent to men in the placebo arm.